Cristina C Belizna

Summary

Country: France

Publications

  1. ncbi Vasculitis and myelodysplasia
    Cristina C Belizna
    Department of Internal Medicine, Rouen University Hospital, Rouen, France
    Isr Med Assoc J 10:156-7. 2008
  2. doi A 5-year prospective follow-up study in essential cryofibrinogenemia patients
    C Belizna
    Internal Medicine Department, University Hospital Angers, 4 rue Larrey, 49000 Angers, France
    Autoimmun Rev 10:559-62. 2011
  3. doi Prognosis of vasculitis associated myelodysplasia
    C Belizna
    Internal Medicine Department, University Hospital Angers, 4 rue Larey, France
    Autoimmun Rev 12:943-6. 2013
  4. doi Arterial stiffness and stroke in sickle cell disease
    Cristina Belizna
    Internal Medicine, University Hospital, 4 rue Larrey, 49000 Angers, France
    Stroke 43:1129-30. 2012
  5. doi Anti-Ku antibodies: Clinical, genetic and diagnostic insights
    C Belizna
    Internal Medicine Department, University Hospital Angers, France
    Autoimmun Rev 9:691-4. 2010
  6. doi Infection and vasculitis
    Cristina C Belizna
    Internal Medicine Department, CHU Rouen, Rouen, France
    Rheumatology (Oxford) 48:475-82. 2009
  7. ncbi Lethal limb ischaemia in leukaemia. Case report and review of the literature
    Cristina Belizna
    Internal Medicine Department CHU Rouen, Rouen, France
    J Thromb Thrombolysis 28:354-7. 2009
  8. doi Antiphospholipid antibodies induce vascular functional changes in mice: a mechanism of vascular lesions in antiphospholipid syndrome?
    C Belizna
    INSERM U644 and Institute for Biomedical Research, IFRMP 23, Rouen University Medical School, Rouen Cedex, France
    Lupus 17:185-94. 2008
  9. doi Outcome of essential cryofibrinogenaemia in a series of 61 patients
    C C Belizna
    Department of Internal Medicine, Rouen University Hospital, 76031 Rouen Cedex, France
    Rheumatology (Oxford) 47:205-7. 2008
  10. ncbi Early atheroma in primary and secondary antiphospholipid syndrome: an intrinsic finding
    Cristina C Belizna
    Department of Internal Medicine, Rouen University Hospital, Rouen, France
    Semin Arthritis Rheum 37:373-80. 2008

Detail Information

Publications12

  1. ncbi Vasculitis and myelodysplasia
    Cristina C Belizna
    Department of Internal Medicine, Rouen University Hospital, Rouen, France
    Isr Med Assoc J 10:156-7. 2008
  2. doi A 5-year prospective follow-up study in essential cryofibrinogenemia patients
    C Belizna
    Internal Medicine Department, University Hospital Angers, 4 rue Larrey, 49000 Angers, France
    Autoimmun Rev 10:559-62. 2011
    ..In a previous study, we reported the occurrence of neoplasia in some essential cryofibrinogenemia patients after a short period of follow-up...
  3. doi Prognosis of vasculitis associated myelodysplasia
    C Belizna
    Internal Medicine Department, University Hospital Angers, 4 rue Larey, France
    Autoimmun Rev 12:943-6. 2013
    ..Most of the authors agree that the median survival in myelodysplastic syndrome is not related to the presence of systemic and immune manifestations, but only with the existence of a systemic vasculitis. ..
  4. doi Arterial stiffness and stroke in sickle cell disease
    Cristina Belizna
    Internal Medicine, University Hospital, 4 rue Larrey, 49000 Angers, France
    Stroke 43:1129-30. 2012
    ..Large vessels are also affected in sickle cell disease. The aim of this study was to assess several parameters in adult patients with sickle cell disease compared with control subjects and in patients with sickle cell disease with stroke...
  5. doi Anti-Ku antibodies: Clinical, genetic and diagnostic insights
    C Belizna
    Internal Medicine Department, University Hospital Angers, France
    Autoimmun Rev 9:691-4. 2010
    ..Moreover, anti-Ku antibodies are not associated with a particular clinical outcome, and especially with cancer related to myositis...
  6. doi Infection and vasculitis
    Cristina C Belizna
    Internal Medicine Department, CHU Rouen, Rouen, France
    Rheumatology (Oxford) 48:475-82. 2009
    ..This inter-relationship is further assessed from the point of view of clinical presentation and therapeutic options, based on case reports and prospective observational data...
  7. ncbi Lethal limb ischaemia in leukaemia. Case report and review of the literature
    Cristina Belizna
    Internal Medicine Department CHU Rouen, Rouen, France
    J Thromb Thrombolysis 28:354-7. 2009
    ..Our report highlights the imperative need for immediate haematological diagnosis despite the non-specific presentation...
  8. doi Antiphospholipid antibodies induce vascular functional changes in mice: a mechanism of vascular lesions in antiphospholipid syndrome?
    C Belizna
    INSERM U644 and Institute for Biomedical Research, IFRMP 23, Rouen University Medical School, Rouen Cedex, France
    Lupus 17:185-94. 2008
    ..We suggest that a sub-population of these autoantibodies could be responsible for the endothelial dysfunction observed in antiphospholipid syndrome...
  9. doi Outcome of essential cryofibrinogenaemia in a series of 61 patients
    C C Belizna
    Department of Internal Medicine, Rouen University Hospital, 76031 Rouen Cedex, France
    Rheumatology (Oxford) 47:205-7. 2008
    ..The present study assessed the outcome of several cases of cryofibrinogenaemia detected in our hospitals during a 10-yr period (December 1996-April 2007), and also attempted to evaluate the clinical manifestations and associated diseases...
  10. ncbi Early atheroma in primary and secondary antiphospholipid syndrome: an intrinsic finding
    Cristina C Belizna
    Department of Internal Medicine, Rouen University Hospital, Rouen, France
    Semin Arthritis Rheum 37:373-80. 2008
    ..The study also explored the relationship between these parameters and cardiovascular risk factors...
  11. ncbi Insights into atherosclerosis therapy in antiphospholipid syndrome
    Cristina C Belizna
    Department of Internal Medicine, Rouen University Hospital, Rouen, France
    Autoimmun Rev 7:46-51. 2007
    ..Furthermore, these data underscore the necessity for the use of other medication for atherosclerosis in APS patients, such as immunomodulatory drugs, which would be complementary to the anti-thrombotic and anti-platelet therapy...
  12. pmc Antiendothelial cell antibodies in vasculitis and connective tissue disease
    C Belizna
    Department of Internal Medicine, CHU Rouen, 147 Avenue du Maréchal Juin, 76000 Rouen, France
    Ann Rheum Dis 65:1545-50. 2006
    ..This review summarises the present knowledge about AECA, AECA antigens and their potential role in the pathogenecity of vasculitis and connective tissue diseases...